pefloxacin has been researched along with Joint Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nazhimov, VP; Novichkova, GA; Postnikov, SS; Semykin, SIu | 1 |
| Aigrain, EJ; Bennasr, S; Brun, P; Loirat, C | 1 |
| Coste-Burel, M; Espaze, EP; Reynaud, AE; Richet, H | 1 |
| Anaya, JM; Baldet, P; Canovas, F; Didry, C; Jorgensen, C; Kahn, MF; Ribard, P; Sany, J; Serre, I | 1 |
| Ait Saït, L; Fessard, C; Le Loët, X; Moore, N; Noblet, C | 1 |
| Arlet, P; Durroux, R; Laroche, M; Le Tallec, Y; Montane, P; Ollier, S | 1 |
| Amar, J; Bouygues, D; Cascarigny, F; Cassou, M; Plantavid, M; Seigneuric, C | 1 |
| Astier, L; Hugot, JP; Kesseler, A; Lacassie, A; Talon, P; Thomas, D | 1 |
| Albengres, E; Chevais, M; Reinert, P; Riant, P; Rondeau, MC; Tillement, JP; Tobelem, R | 1 |
1 trial(s) available for pefloxacin and Joint Diseases
| Article | Year |
|---|---|
[On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data)].
Topics: Adolescent; Age Factors; Anemia, Aplastic; Anti-Infective Agents; Body Height; Cartilage; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Infant; Joint Diseases; Knee Joint; Male; Ofloxacin; Pefloxacin; Prospective Studies; Treatment Outcome | 2002 |
9 other study(ies) available for pefloxacin and Joint Diseases
| Article | Year |
|---|---|
Fluoroquinolones in children: poorly defined risk of joint damage.
Topics: Animals; Anti-Infective Agents; Cartilage; Child; Contraindications; Dogs; Fluoroquinolones; Humans; Joint Diseases; Knee Joint; Pefloxacin; Treatment Outcome | 2004 |
Side-effects of pefloxacin in idiopathic nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Humans; Joint Diseases; Nephrotic Syndrome; Pefloxacin | 1993 |
[In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
Topics: Bone Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fusidic Acid; Humans; In Vitro Techniques; Joint Diseases; Methicillin; Methicillin Resistance; Ofloxacin; Pefloxacin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 1992 |
[Arthropathy with achilles tendon involvement induced by pefloxacin. Apropos of a case].
Topics: Achilles Tendon; Aged; Humans; Joint Diseases; Male; Pefloxacin; Rupture | 1991 |
Severe polyarthropathy in an adolescent treated with pefloxacin.
Topics: Adolescent; Female; Humans; Joint Diseases; Pefloxacin; Respiratory Tract Infections | 1991 |
[Arthropathy caused by pefloxacin. Report of a case. Histologic study of the synovia].
Topics: Adolescent; Female; Humans; Joint Diseases; Knee Joint; Pefloxacin; Synovial Membrane | 1990 |
[Joint manifestations of pefloxacin in adolescents].
Topics: Adolescent; Female; Humans; Joint Diseases; Male; Pefloxacin | 1990 |
[Arthropathies following the administration of pefloxacin to an adolescent with mucoviscidosis].
Topics: Adolescent; Cystic Fibrosis; Humans; Joint Diseases; Knee Joint; Male; Pefloxacin; Pseudomonas Infections; Respiratory Tract Infections | 1989 |
Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.
Topics: Acidosis; Adolescent; Animals; Anti-Infective Agents; Cartilage, Articular; Child; Humans; Infant; Joint Diseases; Norfloxacin; Osteochondritis; Pain; Pefloxacin; Risk | 1987 |